PTEN and familial pancreatic carcinoma: According to in vivo and in vitro studies, phosphatase and tensin homolog (PTEN) loss promotes tumorigenesis and metastatic potential in pancreatic cancer by activating the downstream PI3K/Akt/mTOR/SREBP signaling pathway; higher levels of esterified cholesterol boost carcinogenesis and metastatic potential [64].